
|Articles|April 8, 2008
GlaxoSmithKline's Rotarix gets regulatory green light
GlaxoSmithKline's vaccine, Rotarix, receives approval for use in children.
Advertisement
Treatments to prevent rotavirus-caused gastroenteritis will soon gain an addition now that a new vaccine has been approved by the Food & Drug Administration.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Provide Tailored Pneumococcal Vaccines to Patients With Down Syndrome
2
Finerenone Shows Benefits for Chronic Kidney Disease for Patients With Type 1 Diabetes
3
FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder
4
Dementia Increases Risk of COVID-19 Infection, Hospitalization for Older Patients
5




















































































































































